Ming Hua Qi
- [Escitalopram for intervention of psychiatric adverse events during peginterferon-alfa-2a and ribavirin treatment for chronic hepatitis C]Minghua Qi
Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China
Nan Fang Yi Ke Da Xue Xue Bao 33:1012-6. 2013..To evaluate the risk factors of psychiatric adverse events associated with PEG interferon and ribavirin treatment for chronic hepatitis C and assess the efficacy of escitalopram intervention for these adverse effects...